Zhitong Financial App News, Dizhe Pharmaceutical (688192.SH) issued an announcement. The company signed a “License Agreement” with AstraZeneca UK Limited (hereinafter referred to as “AstraZeneca”) on July 14, 2026, granting AstraZeneca the exclusive right to develop and commercialize Schwarzer® on a global scale. All the conditions for entry into force of the agreement agreed in the agreement have been met, and the agreement officially entered into force on August 31, 2026. AstraZeneca will commercialize Schwarzer® in the US in the fourth quarter of this year.

Zhitongcaijing · 1d ago
Zhitong Financial App News, Dizhe Pharmaceutical (688192.SH) issued an announcement. The company signed a “License Agreement” with AstraZeneca UK Limited (hereinafter referred to as “AstraZeneca”) on July 14, 2026, granting AstraZeneca the exclusive right to develop and commercialize Schwarzer® on a global scale. All the conditions for entry into force of the agreement agreed in the agreement have been met, and the agreement officially entered into force on August 31, 2026. AstraZeneca will commercialize Schwarzer® in the US in the fourth quarter of this year.